Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Medical Plaza
#365,530,420,120
Los Angeles, CA 90074Phone+1 310-825-6301- Is this information wrong?
Education & Training
University of California (San Diego) Medical CenterFellowship, Rheumatology, 2000 - 2003
Scripps Clinic/Scripps Green HospitalFellowship, Allergy and Immunology, 1999 - 2002
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1997 - 1999
Johns Hopkins University School of MedicineClass of 1995
Certifications & Licensure
NY State Medical License 2002 - 2025
CA State Medical License 1999 - 2023
TX State Medical License 1997 - 2023
Publications & Presentations
PubMed
- 246 citationsA Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease.Stephan R. Targan, Brian G. Feagan, Severine Vermeire, Remo Panaccione, Gil Y. Melmed, Carol J. Landers, Dalin Li, Chris B. Russell, Richard Newmark, Nan Zhang, Yun Ch...> ;The American Journal of Gastroenterology. 2016 Aug 2
- 52 citationsA Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to MethotrexateKarel Pavelka, Yun Chon, Richard Newmark, Shao-Lee Lin, Scott Baumgartner, Ngozi Erondu> ;The Journal of Rheumatology. 2015 Apr 15
- 38 citationsClinical trial safety and mortality analyses in patients receiving etanercept across approved indicationsAlice B. Gottlieb, Kenneth B. Gordon, Edward H. Giannini, Philip J. Mease, Juan Li, Yun Chon, Judy Maddox, Haoling H. Weng, Joseph Wajdula, Shao Lee Lin, Scott Baumgar...> ;Journal of Drugs in Dermatology. 2011 Mar 1
- Join now to see all
Press Mentions
ACELYRIN Acquires ValenzaBio, Strengthens Immunology PositionJanuary 6th, 2023
Integrated Clinical Trial Analyses Further Substantiate That Teprotumumab Significantly Improves Debilitating Effects of Thyroid Eye Disease, Including Eye Bulging, Double Vision and Quality of LifeOctober 31st, 2019
American Journal of Ophthalmology (AJO) Publishes Review Highlighting Lack of Treatments for Active Thyroid Eye Disease (TED)August 19th, 2019- Join now to see all
Hospital Affiliations
VA Palo Alto Heath CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
